by Rachel Montague | Jul 15, 2024 | Industry insights
Written by Susan O’Connell, Louise Crathorne, & Sneha Bhadti In the realm of healthcare innovation, the European Union (EU) is paving the way with the Joint Clinical Assessment (JCA) process In this background article, Source aims to highlight some of the...
by Rachel Montague | Jul 1, 2024 | Uncategorised
Written by Ciara Thomas, Vicky Crowe, & David Pritchett Introduction To achieve optimal patient outcomes, systematic literature reviews (SLRs) must synthesise high quality, contemporary evidence to inform health policy and practice (1, 2). SLRs can be time...
by Rachel Montague | Jul 25, 2022 | Industry insights
Written by Beth Hancock, Senior Consultant Health Economist Pharmaceutical companies often develop global cost-effectiveness and budget impact models, with the aim of adapting them for specific countries. In principle, this is an efficient and streamlined process, but...
by Rachel Montague | Jun 17, 2022 | Industry insights, Source news, Uncategorised
Written by Alec Miners, Head of Health Economics The National Institute for Health and Care Excellence’s (NICE’s) new processes and methods guide includes several important changes to the way submitted economic evaluations should be conducted (1). While the headline...
by Rachel Montague | Jun 15, 2022 | Source news
As we approach the end of British Heart Week, we reflect on some of the key stats around heart conditions in the UK and our contribution as a company to help bring cutting-edge treatments to patients with cardiovascular diseases
